News

Alphabet was targeted with an EU antitrust complaint from six human and digital rights groups on Thursday which urged EU ...
The organisations claim that Alphabet has violated the EU Digital Markets Act's requirements regarding app uninstallation on ...
Still, this month, Alphabet’s Google also faced an EU antitrust complaint from independent publishers who alleged that the tech company’s AI Overviews resulted in serious damages that have greatly ...
Alphabet’s Isomorphic Labs is preparing to launch human trials of AI-designed drugs, its president, Colin Murdoch, told Fortune. Born from DeepMind’s AlphaFold breakthrough, the company is ...
Alphabet (NasdaqGS:GOOGL) saw its share price rise by 3% over the last month. Several factors may have influenced this move. The company's announcement of significant increases in both dividend ...
Alphabet’s secretive drug discovery arm, Isomorphic Labs, is getting ready to start testing its AI-designed drugs in humans, Colin Murdoch, Isomorphic Labs president and Google DeepMind’s chief ...